Sign in

CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010382980
Phone
2078782770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Open-market buy President and CEO bought 9,785 shares at an average $4.97 ($48,588)
  2. 4 Open-market buy Director bought 3,266 shares at an average $4.76 ($15,554)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Option exercise Director acquired 3,530 shares (option exercise)
  6. 4 Open-market buy Director bought 1,000 shares at $6.32 ($6,320)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Returned to the company Director returned 2,186 shares (to the company)
  15. 4 Returned to the company Director returned 6,005 shares (to the company)
  16. 4 Returned to the company Director returned 10,000 shares (to the company)
  17. 4 Returned to the company Director returned 10,000 shares (to the company)
  18. 4 Returned to the company Director returned 3,100 shares (to the company)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 2 of 13 · 255 filings